Overview
?
LAI PING CHAN
See more contacts
Other Ambulatory Health Care Services
,
Ambulatory Health Care Services
,
Health Care and Social Assistance
,
Health and allied services, nec
,
Personal holding companies, except banks
Child Care Services
,
Community Food and Housing, and Emergency and Other Relief Services
,
Continuing Care Retirement Communities and Assisted Living Facilities for the Elderly
,
General Medical and Surgical Hospitals
,
Home Health Care Services
,
Individual and Family Services
,
Medical and Diagnostic Laboratories
,
Nursing Care Facilities (Skilled Nursing Facilities)
View more , Offices of Dentists , Offices of Other Health Practitioners , Offices of Physicians , Other Residential Care Facilities , Outpatient Care Centers , Psychiatric and Substance Abuse Hospitals , Residential Intellectual and Developmental Disability, Mental Health, and Substance Abuse Facilities , Specialty (except Psychiatric and Substance Abuse) Hospitals Vocational Rehabilitation Services
View fewer
View more , Offices of Dentists , Offices of Other Health Practitioners , Offices of Physicians , Other Residential Care Facilities , Outpatient Care Centers , Psychiatric and Substance Abuse Hospitals , Residential Intellectual and Developmental Disability, Mental Health, and Substance Abuse Facilities , Specialty (except Psychiatric and Substance Abuse) Hospitals Vocational Rehabilitation Services
View fewer
?
$8.86 million
Actual
-6.94%
$1,171
DEC
?
?
Hong Kong:00397
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2024 (12 month period) in USD
Annual Revenue 2024
$8.86 million
USD
Actual
1 USD = 7.7808 HKD
All financial statement data is in millions except per share data | Source: Morningstar
Cash Flow (mil) | 2024 | 2023 | 2022 |
---|---|---|---|
Net Operating Cash | -$3 | $8 | $10 |
Net Investing Cash | -$2 | -$6 | -$4 |
Net Financing Cash | -$0 | -$5 | $2 |
Net Change in Cash | -$6 | -$4 | $9 |
Cash at Beginning of Period | $24 | $28 | $20 |
Cash at End of Period | $18 | $24 | $28 |
Capital Expenditure | -$2 | -$2 | -$0 |
Assets (mil) | 2024 | 2023 | 2022 |
---|---|---|---|
Current Assets | |||
Cash and Cash Equivalents | $18 | $24 | $28 |
Accounts Receivable | $14 | $16 | $19 |
Inventories | $ | $ | $ |
Other Current Assets | $97 | $105 | $124 |
Asset Summary | |||
Total Current Assets | $129 | $145 | $171 |
Tangible Fixed Assets | $3 | $1 | $0 |
Intangible Assets | $1 | $1 | $0 |
Total Assets | $1,172 | $1,326 | $1,473 |
Liabilities (mil) | 2024 | 2023 | 2022 |
---|---|---|---|
Current Liabilities | |||
Accounts Payable | $1 | $2 | $2 |
Short-Term Debt | $3 | $3 | $3 |
Other Current Liabilities | $1 | $1 | $2 |
Liability Summary | |||
Total Current Liabilities | $5 | $6 | $7 |
Long-Term Debt | $ | $ | $ |
Other Long-Term Liabilities | $ | $ | $ |
Total Liabilities | $5 | $6 | $7 |
Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
---|---|---|---|
Equity | |||
Common Stock | $3 | $3 | $4 |
Retained Earnings | $142 | $160 | $178 |
Equity Summary | |||
Total Equity | $145 | $164 | $182 |
Shares Outstanding | 2,505,282,734 | 2,505,282,734 | 2,783,552,734 |